New 1,4-dihydropyridine derivatives combining calcium antagonism and alpha-adrenolytic properties

J Med Chem. 1989 Jun;32(6):1402-7. doi: 10.1021/jm00126a042.

Abstract

A series of twelve 1,4-dihydropyridine derivatives incorporating an alpha-adrenergic moiety in one of the ester chains was synthesized. The compounds were evaluated for their calcium antagonist activities by the inhibition of [3H]nitrendipine binding and, in vitro, on pig coronary artery. Their alpha 1- and alpha 2-adrenolytic effects were assessed from their inhibition of [3H]prazosin and [3H]yohimbine binding and, in vitro, on rat aorta and guinea pig vas deferens. Compounds 6 and 9-11 displayed strong calcium antagonist activities, identical with that of nicardipine. The moderate alpha-adrenolytic properties observed were attributed to the presence of alpha-adrenergic moieties. The four chiral derivatives 6a (R,R), 6b (S,S), 6c (S,R), and 6d (R,S) with an N-methyl-N-(benzodioxanylmethyl)amino group on the ester chain were prepared and tested as done previously. Some structure-activity relationships are discussed.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aorta / metabolism
  • Calcium Channel Blockers / chemical synthesis*
  • Calcium Channel Blockers / pharmacology
  • Calcium Chloride / pharmacology
  • Cerebral Cortex / metabolism
  • Chemical Phenomena
  • Chemistry
  • Coronary Vessels / physiology
  • Dihydropyridines / chemical synthesis
  • Dihydropyridines / pharmacology*
  • Guinea Pigs
  • Male
  • Molecular Structure
  • Muscle Contraction / drug effects
  • Nitrendipine / metabolism
  • Prazosin / metabolism
  • Rats
  • Receptors, Adrenergic, alpha / drug effects*
  • Receptors, Adrenergic, alpha / metabolism
  • Swine
  • Vas Deferens / metabolism
  • Yohimbine / metabolism

Substances

  • Calcium Channel Blockers
  • Dihydropyridines
  • Receptors, Adrenergic, alpha
  • Yohimbine
  • Nitrendipine
  • Calcium Chloride
  • Prazosin